10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

GILEAD SCIENCES, INC.

Ticker: GILD   Fiscal Year: 2020

Consolidated Statements of Income

Period Ending Dec 31, 2020 10-K (Filed: Feb 25, 2021)

(In Millions)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2020Dec 31, 2019Dec 31, 2018
Revenues:
Revenues
$
24,689
22,44922,127
Costs and expenses:
Cost of goods sold4,5724,6754,853
Research and development expenses5,0394,0553,920
Acquired in-process research and development expenses5,8565,0511,098
Selling, general and administrative expenses5,1514,3814,056
Total costs and expenses20,61818,16213,927
 
Income from operations4,0714,2878,200
 
Interest expense(984)(995)(1,077)
Other income (expense), net(1,418)1,868676
Income before income taxes1,6695,1607,799
 
Income tax expense (benefit)1,580(204)2,339
Net income895,3645,460
 
Net (loss) income attributable to noncontrolling interest(34)(22)5
Net income attributable to Gilead1235,3865,455
 
Net income per share attributable to Gilead common stockholders - basic (usd per share)0.104.244.20
Shares used in per share calculation - basic (in shares)1,2571,2701,298
Net income per share attributable to Gilead common stockholders - diluted (usd per share)0.104.224.17
Shares used in per share calculation - diluted (in shares)1,2631,2771,308
Product and Service
Product sales
Revenues24,35522,11921,677
Royalty, contract and other revenues
Revenues334330450
External Links 
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2020
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip